Adam S Cheifetz

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Percutaneous Coronary Intervention

Angiotensin Converting Enzyme

Top Venues

Alimentary pharmacology & therapeutics

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Natália Souza Freitas Queiroz, Konstantinos Papamichael, Adam S Cheifetz
Letter: is blindly stopping thiopurines without confirming adequate anti-TNF concentrations shortsighted? Alimentary pharmacology & therapeutics 55 (7) (2022)
Laurie B Grossberg, Konstantinos Papamichael, Adam S Cheifetz
Review article: emerging drug therapies in inflammatory bowel disease. Alimentary pharmacology & therapeutics 55 (7) (2022)
Shana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD? Alimentary pharmacology & therapeutics 55 (8) (2022)
Shana Rakowsky, Adam S Cheifetz, Konstantinos Papamichael
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease. Alimentary pharmacology & therapeutics 54 (8) (2021)
Joseph D Frasca, Adam S Cheifetz
Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease-results from the ENEIDA registry. Alimentary pharmacology & therapeutics 50 (5) (2020)
Sveta Shah Oza, Vikas Pabby, Laura E Dodge, Michele R Hacker, Janis H Fox, Vasiliki A Moragianni, Katharine Correia, Stacey A Missmer, Yetunde Ibrahim, Alan S Penzias, Robert Burakoff, Sonia Friedman, Adam S Cheifetz
Factors Associated with the Success of In Vitro Fertilization in Women with Inflammatory Bowel Disease. Digestive diseases and sciences 61 (8) (2016)